169
Views
0
CrossRef citations to date
0
Altmetric
Perspectives in Rehabilitation

A perspective on a precision approach to pain in cancer; moving beyond opioid therapy

ORCID Icon, ORCID Icon, , , , & show all
Pages 2174-2183 | Received 11 Sep 2022, Accepted 07 May 2023, Published online: 17 May 2023

References

  • Anon. Lifetime Risk of Developing or Dying From Cancer. [cited 2022 June 4]. Available from: https://www.cancer.org/healthy/cancer-causes/general-info/lifetime-probability-of-developing-or-dying-from-cancer.html.
  • Evenepoel M, Haenen V, De Baerdemaecker T, et al. Pain prevalence during cancer treatment: a systematic review and meta-analysis. J Pain Symptom Manage. 2022;63(3):e317–e335.
  • Sanford NN, Sher DJ, Butler SS, et al. Prevalence of chronic pain among cancer survivors in the United States, 2010-2017. Cancer. 2019; December 1125(23):4310–4318.
  • Alese OB, Zhang C, Zakka KM, et al. A cost analysis of managing cancer-related pain among hospitalized US cancer patients. J Clin Oncol. 2020; May 2038(15_suppl):7079–7079.
  • Wiffen PJ, Wee B, Moore RA. Oral morphine for cancer pain. Cochrane Database of Systematic Reviews [Internet]. 2016. [cited 2022 June 4]. Available from: 10.1002/14651858.CD003868.pub4/full?highlightAbstract=morphin%7Cpain%7Ccancer%7Cmorphine.
  • Schmidt-Hansen M, Bennett MI, Arnold S, et al. Oxycodone for cancer-related pain. Cochrane Database of Systematic Reviews [Internet]. 2017 [cited 2022 June 4]. Available from: 10.1002/14651858.CD003870.pub6/full?highlightAbstract=morphin%7Cpain%7Ccancer%7Cmorphine.
  • Nicholson AB, Watson GR, Derry S, et al. Methadone for cancer pain. Cochrane Database of Systematic Reviews [Internet]. 2017 [cited 2022 June 4]. Available from: 10.1002/14651858.CD003971.pub4/full?highlightAbstract=morphin%7Cpain%7Ccancer%7Cmorphine.
  • Li Y, Ma J, Lu G, et al. Hydromorphone for cancer pain. Cochrane Database of Systematic Reviews [Internet]. 2021 [cited 2022 June 4]. Available from: 10.1002/14651858.CD011108.pub3/full?highlightAbstract=morphin%7Cpain%7Ccancer%7Cmorphine.
  • Hadley G, Derry S, Moore RA, et al. Transdermal fentanyl for cancer pain. Cochrane Database of Systematic Reviews [Internet]. 2013. [cited 2022 June 4]. Available from: 10.1002/14651858.CD010270.pub2/full?highlightAbstract=morphin%7Cpain%7Ccancer%7Cmorphine.
  • Mercadante S. Opioid analgesics adverse effects: the other side of the coin. Curr Pharm Des. 2019;25(30):3197–3202.
  • American Cancer Society Cancer Action Network. Patient Quality of Life Coalition: Key Findings Summary: Opioid Access Research Project. 2018 June [cited 2022 April 24]. Available from: https://www.fightcancer.org/sites/default/files/ACS%20CAN%20PQLC%20Opioid%20Research%20Project%20Key%20Findings%20Summary%20Memo%20FINAL.pdf.
  • Bulls HW, Hoogland AI, Craig D, et al. Cancer and opioids: patient experiences with stigma (COPES)-a pilot study. J Pain Symptom Manage. 2019;57(4):816–819.
  • Niles JK, Gudin J, Radcliff J, et al. The opioid epidemic within the COVID-19 pandemic: drug testing in 2020. Popul Health Manag. 2021;24(S1): S 43–S51.
  • Kosten TR, Petrakis IL. The hidden epidemic of opioid overdoses during the coronavirus disease 2019 pandemic. JAMA Psychiatry. 2021;78(6):585–586.
  • Agnoli A, Xing G, Tancredi DJ, et al. Association of dose tapering with overdose or mental health crisis among patients prescribed long-term opioids. JAMA. 2021; August 3326(5):411–419.
  • Anon. Ending America’s Opioid Crisis–The White House. [cited 2022 June 4]. Available from: https://trumpwhitehouse.archives.gov/opioids/.
  • Anon. CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016. MMWR Recomm Rep [Internet]. 2016 [cited 2022 June 4];65. Available from: https://www.cdc.gov/mmwr/volumes/65/rr/rr6501e1.htm.
  • Anon. CDC Issues Updated Guideline for Prescribing Opioids. AAMC [Internet]. [cited 2022 June 5]. Available from: https://www.aamc.org/advocacy-policy/washington-highlights/cdc-issues-updated-guideline-prescribing-opioids.
  • Anon. Process for Updating the Opioid Prescribing Guideline | CDC’s Response to the Opioid Overdose Epidemic | CDC. 2022 April 15 [cited 2022 June 5]. Available from: https://www.cdc.gov/opioids/guideline-update/index.html.
  • Tsimberidou AM, Fountzilas E, Nikanjam M, et al. Review of precision cancer medicine: evolution of the treatment paradigm. Cancer Treat Rev. 2020; June 86:102019.
  • Morganti S, Tarantino P, Ferraro E, et al. Next generation sequencing (NGS): a revolutionary technology in pharmacogenomics and personalized medicine in cancer. Adv Exp Med Biol. 2019;1168:9–30.
  • Zhang Y, Zhang Z. The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications. Cell Mol Immunol. 2020;17(8):807–821.
  • Sabik LM, Eom KY, Sun Z, et al. Patterns and trends in receipt of opioids among patients receiving treatment for cancer in a large health system. J Natl Compr Canc Netw. 2022; 20(5):460–467.e1.
  • Bovero A, Digiovanni Y, Botto R, et al. End-of-life cancer patients’ total pain: the necessity to supplement pharmacology with psycho-socio-spiritual treatments. Pain Manag. 2022; 12(8):895–906.
  • Otis-Green S, Sherman R, Perez M, et al. An integrated psychosocial-spiritual model for cancer pain management. Cancer Pract. 2002;10 Suppl 1(Suppl 1):S58–S65.
  • Ray WA, Chung CP, Murray KT, et al. Prescription of long-acting opioids and mortality in patients with chronic noncancer pain. JAMA. 2016; June 14315(22):2415–2423.
  • Bennett MI, Kaasa S, Barke A, et al. The IASP classification of chronic pain for ICD-11: chronic cancer-related pain. Pain. 2019;160(1):38–44.
  • International Association for the Study of Pain. Terminology. International Association for the Study of Pain (IASP) [Internet]. [cited 2022 April 25]. Available from: https://www.iasp-pain.org/resources/terminology/.
  • Gold M. Peripheral pain mechanisms and nocicepter sensitization. In: bonica’s management of pain. 5th ed. Philadelphia, PA: Wolters Kluwer; 2019. pp 24–34.
  • Vijjeswarapu M, Sundararaman L, Ross E. Cancer-related visceral pain. In Bonica’s management of pain. 5th ed. Philadelphia, PA: Wolters Kluwer; 2019. pp 751–754.
  • Ross E, Sundararaman L, Vijjeswarapu M. Cancer-related bone pain. In Bonica’s management of pain. 5th ed. Philadelphia, PA: Wolters Kluwer; 2019. pp 744–745.
  • Dalal S, Bruera E. Chapter 3: introduction to pain. In: the M.D. Anderson supportive and palliative care handbook. Houston, TX: University of Texas M.D. Anderson Cancer Center; 2015. pp 11–15.
  • Fitzgibbon D. Assessment and diagnosis of the cancer patient with pain. In Bonica’s management of pain. 5th ed. Philadelphia, PA: wolters Kluwer; 2019. pp 621–628.
  • Fitzcharles M-A, Cohen SP, Clauw DJ, et al. Nociplastic pain: towards an understanding of prevalent pain conditions. Lancet. 2021;397(10289):2098–2110.
  • Harte SE, Harris RE, Clauw DJ. The neurobiology of central sensitization. J Appl Behav Res. 2018;23(2):e12137.
  • Smallwood RF, Laird AR, Ramage AE, et al. Structural brain anomalies and chronic pain: a quantitative meta-analysis of gray matter volume. J Pain. 2013;14(7):663–675.
  • Clauw DJ. Fibromyalgia: a clinical review. JAMA. 2014; 311(15):1547–1555.
  • Clauw DJ. Fibromyalgia and related conditions. Mayo Clin Proc. 2015 May; 90(5):680–692.
  • Brummett CM, Urquhart AG, Hassett AL, et al. Characteristics of fibromyalgia independently predict poorer long-term analgesic outcomes following total knee and hip arthroplasty. Arthritis Rheumatol. 2015;67(5):1386–1394.
  • Clauw DJ, Hassett AL. The role of centralised pain in osteoarthritis. Clin Exp Rheumatol. 2017;35:S79–S84.
  • Grigorian N, Baumrucker SJ. Aromatase inhibitor-associated musculoskeletal pain: an overview of pathophysiology and treatment modalities. SAGE Open Med. 2022;10:205031212210787.
  • Wisotzky E, Power K. Aromtase inhibitor-induced musculoskeletal symptoms. In: cancer rehabilitation: principles and practice. 2nd ed. New York: Demos Medical; 2018.
  • Roberts KE, Adsett IT, Rickett K, et al. Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer. Cochrane Database Syst Rev. 2022 January 10;1(1):CD013167.
  • Roberts KE, Rickett K, Feng S, et al. Exercise therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer. Cochrane Database Syst Rev. 2020;1(1):CD012988.
  • Farkas AH, Winn A, Pezzin LE, et al. The use and concurrent use of side effect controlling medications among women on aromatase inhibitors. J Womens Health. 2021;30(1):131–136.
  • Merskey H, Bogduk N. International association for the study of pain eds. Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms. 2nd ed. Seattle: IASP Press; 1994.
  • Waltho D, Rockwell G. Post-breast surgery pain syndrome: establishing a consensus for the definition of post-mastectomy pain syndrome to provide a standardized clinical and research approach–a review of the literature and discussion. Can J Surg. 2016;59(5):342–350.
  • Chappell AG, Bai J, Yuksel S, et al. Post-mastectomy pain syndrome: defining perioperative etiologies to guide new methods of prevention for plastic surgeons. World J Plast Surg. 2020;9(3):247–253.
  • Chang PJ, Asher A, Smith SR. A targeted approach to Post-Mastectomy pain and persistent pain following breast cancer treatment. Cancers. 2021;13(20):5191.
  • Tait RC, Zoberi K, Ferguson M, et al. Persistent post-mastectomy pain: risk factors and current approaches to treatment. J Pain. 2018;19(12):1367–1383.
  • Khoury AL, Keane H, Varghese F, et al. Trigger point injection for post-mastectomy pain: a simple intervention with high rate of long-term relief. NPJ Breast Cancer. 2021;77(1):123.
  • Yang A, Nadav D, Legler A, et al. An interventional pain algorithm for the treatment of postmastectomy pain syndrome: a single-center retrospective review. Pain Med. 2021;22(3):677–686.
  • Lee JS-J, Hu HM, Edelman AL, et al. New persistent opioid use among patients with cancer after curative-intent surgery. J Clin Oncol. 2017;35(36):4042–4049.
  • Cogan JC, Raghunathan RR, Beauchemin MP, et al. New and persistent controlled substance use among patients undergoing mastectomy and reconstructive surgery. Breast Cancer Res Treat. 2021;189(2):445–454.
  • Jones KF, Wechsler S, Zulewski D, et al. Pharmacological and nonpharmacological management of chemotherapy-induced peripheral neuropathy: a scoping review of randomized controlled trials. J Palliat Med. 2022;25(6):964–995.
  • Seretny M, Currie GL, Sena ES, et al. Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Pain. 2014;155(12):2461–2470.
  • Staff NP, Grisold A, Grisold W, et al. Chemotherapy-induced peripheral neuropathy: a current review. Ann Neurol. 2017;81(6):772–781.
  • Loprinzi CL, Lacchetti C, Bleeker J, et al. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update. J Clin Oncol. 2020;38(28):3325–3348.
  • Lohse I, Brothers SP. Pathogenesis and treatment of pancreatic cancer related pain. Anticancer Res. 2020; April 40(4):1789–1796.
  • Coveler AL, Mizrahi J, Eastman B, et al. Pancreas cancer-associated pain management. Oncologist. 2021;26(6):e971–e982.
  • Carvajal G. Pancreatic cancer related pain: review of pathophysiology and intrathecal drug delivery systems for pain management. Pain Physician. 2021;24(5):E583–E594.
  • Anon. Acute to Chronic Pain Signatures. 2017 September 28 [cited 2022 April 25]. Available from: https://commonfund.nih.gov/pain.
  • Leysen L, Adriaenssens N, Nijs J, et al. Chronic pain in breast cancer survivors: nociceptive, neuropathic, or central sensitization pain? Pain Pract. 2019;19(2):183–195.
  • Manfuku M, Nishigami T, Mibu A, et al. Comparison of central sensitization-related symptoms and health-related quality of life between breast cancer survivors with and without chronic pain and healthy controls. Breast Cancer. 2019;26(6):758–765.
  • Portenoy R, Mehta Z, Ahmed E. Prevention and management of side effects in patients receiving opioids for chronic pain. UpToDate [Internet]. 2022 January 3 [cited 2022 April 25]. Available from:https://www.uptodate.com/contents/prevention-and-management-of-side-effects-in-patients-receiving-opioids-for-chronic-pain?search=opioid%20side%20effects&source=search_result&selectedTitle=3∼145&usage_type=default&display_rank=1.
  • Azizoddin DR, Knoerl R, Adam R, et al. Cancer pain self-management in the context of a national opioid epidemic: experiences of patients with advanced cancer using opioids. Cancer. 2021;127(17):3239–3245.
  • Brooks JV, Poague C, Formagini T, et al. Palliative care’s role managing cancer pain during the opioid crisis: a qualitative study of patients, caregivers, and clinicians. J Pain Symptom Manage. 2020;60(6):1127–1135.e2.
  • Lugg W. The biopsychosocial model - history, controversy and engel. Australas Psychiatry. 2022;30(1):55–59.
  • Wood JCS. “Total pain” and emotional evidence at the end of life. Med Humanit. 2021;48:411–420. medhum-2020-012107.
  • Boucher E, Rosgen B, Lang E. Efficacy of calcitonin for treating acute pain associated with osteoporotic vertebral compression fracture: an updated systematic review. CJEM. 2020 May; 22(3):359–367.
  • Nijs J, Leysen L, Adriaenssens N, et al. Pain following cancer treatment: guidelines for the clinical classification of predominant neuropathic, nociceptive and central sensitization pain. Acta Oncol. 2016; June 55(6):659–663.
  • Davis M, Dalal S, Goforth H, et al. Pain management. In: Joseph WS, Miguel AP, editors. UNIPAC 3: pain assessment and management. 5th ed. Chicago, IL: American Academy of Hospice and Palliative Medicine; 2017. pp 27–104.
  • Heung Y, Reddy A, Reddy S. Chapter 4: pain management. In The MD anderson supportive and palliative care handbook. 5th ed. Houston, TX: American Academy of Hospice and Palliative Medicine; 2015. pp 16–37.
  • National Institute for Health and Care Excellence. Neuropathic pain in adults: pharmacological management in non-specialist settings. London: National Institute for Health and Care Excellence (UK); 2020. Available from: http://www.ncbi.nlm.nih.gov/books/NBK552848/
  • Sumitani M, Sakai T, Matsuda Y, et al. Executive summary of the clinical guidelines of pharmacotherapy for neuropathic pain: second edition by the Japanese Society of pain clinicians. J Anesth. 2018; June 132(3):463–478.
  • Western Australian Therapeutic Advisory Group. Guidelines for the Pharmacological Treatment of Neuropathic Pain. Government of Western Australia Department of Health [Internet]. 2017 [cited 2021 August 31]. Available from: https://ww2.health.wa.gov.au/∼/media/Files/Corporate/general%20documents/WATAG/Neuropathic-Pain-Guidelines.pdf.
  • Finnerup NB, Attal N, Haroutounian S, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015;14(2):162–173.
  • Moulin D, Boulanger A, Clark A, et al. Pharmacological management of chronic neuropathic pain: revised consensus statement from the Canadian pain society. Pain Res Manag. 2014;19(6):328–335.
  • Wang H-L, Donovan KA, Rajasekhara S, et al. The pre-efficacy phase testing for PAfitMETM—a behavioral physical activity intervention to manage moderate and severe symptoms among advanced stage cancer patients. Res Nurs Health. 2021;44(1):238–249.
  • Zimmer P, Trebing S, Timmers-Trebing U, et al. Eight-week, multimodal exercise counteracts a progress of chemotherapy-induced peripheral neuropathy and improves balance and strength in metastasized colorectal cancer patients: a randomized controlled trial. Support Care Cancer. 2018;26(2):615–624.
  • Hilfiker R, Meichtry A, Eicher M, et al. Exercise and other non-pharmaceutical interventions for cancer-related fatigue in patients during or after cancer treatment: a systematic review incorporating an indirect-comparisons meta-analysis. Br J Sports Med. 2018;52(10):651–658.
  • Cantarero-Villanueva I, Cuesta-Vargas AI, Lozano-Lozano M, et al. Changes in pain and muscle architecture in colon cancer survivors after a lumbopelvic exercise program: a secondary analysis of a randomized controlled trial. Pain Med. 2017;18(7):1366–1376.
  • Capozzi LC, Nishimura KC, McNeely ML, et al. The impact of physical activity on health-related fitness and quality of life for patients with head and neck cancer: a systematic review. Br J Sports Med. 2016;50(6):325–338.
  • Skelly AC, Chou R, Dettori JR, et al. Noninvasive nonpharmacological treatment for chronic pain: a systematic review update. Rockville (MD): Agency for Healthcare Research and Quality (US); 2020. Available from: http://www.ncbi.nlm.nih.gov/books/NBK556229/
  • Arnold LM, Clauw DJ. Challenges of implementing fibromyalgia treatment guidelines in current clinical practice. Postgrad Med. 2017;129(7):709–714.
  • Ferro Moura Franco K, Lenoir D, Dos Santos Franco YR, et al. Prescription of exercises for the treatment of chronic pain along the continuum of nociplastic pain: a systematic review with meta-analysis. Eur J Pain. 2021; January 25(1):51–70.
  • Campbell KL, Winters-Stone KM, Wiskemann J, et al. Exercise guidelines for cancer survivors: consensus statement from international multidisciplinary roundtable. Med Sci Sports Exerc. 2019; November 51(11):2375–2390.
  • American Cancer Society. American Cancer Society Guideline for Diet and Physical Activity. [cited 2022 March 28]. Available from: https://www.cancer.org/healthy/eat-healthy-get-active/acs-guidelines-nutrition-physical-activity-cancer-prevention/guidelines.html.
  • National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Survivorship. 2021 August 23. [cited 2022 March 28]. Available from: https://www.nccn.org/professionals/physician_gls/pdf/survivorship.pdf.
  • Loh KP, Zittel J, Kadambi S, et al. Elucidating the associations between sleep disturbance and depression, fatigue, and pain in older adults with cancer. J Geriatr Oncol. 2018;9(5):464–468.
  • Jakobsen G, Engstrøm M, Fayers P, et al. Sleep quality with WHO step III opioid use for cancer pain. BMJ Support Palliat Care. 2019;9(3):307–315.
  • Rakhimov A, Whibley D, Tang NKY. Cognitive-behavioural pathways from pain to poor sleep quality and emotional distress in the general population: the indirect effect of sleep-related anxiety and sleep hygiene. PLOS One. 2022; 17(1):e0260614.
  • Whibley D, AlKandari N, Kristensen K, et al. Sleep and pain a systematic review of studies of mediation. Clin J Pain. 2019; 35(6):544–558.
  • Whibley D, Williams DA, Clauw DJ, et al. Sleep duration moderates the association between next-day physical activity and pain intensity among women with fibromyalgia. Sleep. 2020;43(Supplement_1):A384–A384.
  • Whibley D, Kratz AL, Murphy SL. Sleep efficiency moderates the next-day association between physical activity and pain intensity among adults with knee osteoarthritis. J Pain. 2022;23(5):59–59.
  • Qaseem A, Kansagara D, Forciea MA, et al. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American college of physicians. Ann Intern Med. 2016; July 19165(2):125–133.
  • sleepio.com. Sleepio. Sleepio [Internet]. [cited 2022 July 18]. Available from: https://www.sleepio.com.
  • Anon. CBT-i Coach | VA Mobile. [cited 2022 July 18]. Available from: https://mobile.va.gov/app/cbt-i-coach.
  • Anon. Go! to Sleep. [cited 2022 July 18]. Available from: https://clevelandclinicwellness.com/pages/GoToSleep.htm.
  • Anon. Missing the mark with melatonin: Finding the best treatment for insomnia. American Academy of Sleep Medicine–Association for Sleep Clinicians and Researchers [Internet]. 2021. February 10 [cited 2022 July 18]. Available from: https://aasm.org/missing-the-mark-melatonin-finding-best-treatment-insomnia/.
  • Elma Ö, Yilmaz ST, Deliens T, et al. Chronic musculoskeletal pain and nutrition: where are We and where are We heading? Pm R. 2020;12(12):1268–1278.
  • Grant RW, Stephens JM. Fat in flames: influence of cytokines and pattern recognition receptors on adipocyte lipolysis. Am J Physiol Endocrinol Metab. 2015;309(3):E205–213.
  • Brain K, Burrows TL, Rollo ME, et al. A systematic review and meta-analysis of nutrition interventions for chronic noncancer pain. J Hum Nutr Diet. 2019;32(2):198–225.
  • Freitas RDS, Campos MM. Protective effects of omega-3 fatty acids in cancer-related complications. Nutrients. 2019;11(5):945.
  • Tümkaya Yılmaz S, Malfliet A, Elma Ö, et al. Diet/nutrition: ready to transition from a cancer recurrence/prevention strategy to a chronic pain management modality for cancer survivors? JCM. 2022;11(3):653.
  • Chabowski M, Polański J, Jankowska-Polańska B, et al. Is nutritional status associated with the level of anxiety, depression and pain in patients with lung cancer? J Thorac Dis. 2018;10(4):2303–2310.
  • Nahin RL, Barnes PM, Stussman BJ. Expenditures on complementary health approaches: United States, 2012. Natl Health Stat Report. 2016;(95):1–11.
  • Forte AJ, Guliyeva G, McLeod H, et al. The impact of optimism on cancer-related and postsurgical cancer pain: a systematic review. J Pain Symptom Manage. 2022;63(2):e203–e211.
  • Lin L-Y, Lin L-H, Tzeng G-L, et al. Effects of mindfulness-based therapy for cancer patients: a systematic review and meta-analysis. J Clin Psychol Med Settings. 2022;29(2):432–445.
  • Ruano A, García-Torres F, Gálvez-Lara M, et al. Psychological and non-pharmacologic treatments for pain in cancer patients: a systematic review and meta-analysis. J Pain Symptom Manage. 2022;63(5):e505–e520.
  • Valentine A, Brown J, Lacourt T, et al. Frequency of anxiety and depression and screening performance of the edmonton symptom assessment scale in a psycho-oncology clinic. Psychooncology. 2022;31(2):290–297.
  • Peng Z, Li L, Chen Y, et al. WeChat app-based reinforced education improves the quality of opioid titration treatment of cancer-related pain in outpatients: a randomized control study. BMC Cancer. 2020;20(1):852.
  • Wachen JS, Patidar SM, Mulligan EA, et al. Cancer-related PTSD symptoms in a veteran sample: association with age, combat PTSD, and quality of life. Psychooncology. 2014;23(8):921–927.
  • Unseld M, Zeilinger EL, Fellinger M, et al. Prevalence of pain and its association with symptoms of post-traumatic stress disorder, depression, anxiety and distress in 846 cancer patients: a cross sectional study. Psychooncology. 2021;30(4):504–510.
  • Sager ZS, Wachen JS, Naik AD, et al. Post-traumatic stress disorder symptoms from multiple stressors predict chronic pain in cancer survivors. J Palliat Med. 2020;23(9):1191–1197.
  • French-Rosas LN, Moye J, Naik AD. Improving the recognition and treatment of cancer-related posttraumatic stress disorder. J Psychiatr Pract. 2011;17(4):270–276.
  • Kelleher SA, Fisher HM, Winger JG, et al. Feasibility, engagement, and acceptability of a behavioral pain management intervention for colorectal cancer survivors with pain and psychological distress: data from a pilot randomized controlled trial. Support Care Cancer. 2021; 29(9):5361–5369.
  • Kelleher SA, Winger JG, Dorfman CS, et al. A behavioral cancer pain intervention: a randomized noninferiority trial comparing in-person with videoconference delivery. Psychooncology. 2019;28(8):1671–1678.
  • Hughes S, Jaremka LM, Alfano CM, et al. Social support predicts inflammation, pain, and depressive symptoms: longitudinal relationships among breast cancer survivors. Psychoneuroendocrinology. 2014;42:38–44.
  • De Laurentis M, Rossana B, Andrea B, et al. The impact of social-emotional context in chronic cancer pain: patient-caregiver reverberations : social-emotional context in chronic cancer pain. Support Care Cancer. 2019;27(2):705–713.
  • Martinez KA, Snyder CF, Malin JL, et al. Is race/ethnicity related to the presence or severity of pain in colorectal and lung cancer? J Pain Symptom Manage. 2014;48(6):1050–1059.
  • Wang H-L, Kroenke K, Wu J, et al. Predictors of cancer-related pain improvement over time. Psychosom Med. 2012;74(6):642–647.
  • Stein KD, Alcaraz KI, Kamson C, et al. Sociodemographic inequalities in barriers to cancer pain management: a report from the American cancer society’s study of cancer Survivors-II (SCS-II). Psychooncology. 2016;25(10):1212–1221.
  • McCabe R, Murray R, Austin P, et al. Spiritual and existential factors predict pain relief in a pain management program with a meaning-based component. J Pain Manag. 2018;11(2):163–170.
  • Lovell M, Corbett M, Dong S, et al. Spiritual well-being in people living with persistent non-cancer and cancer-related pain. Pain Med. 2021;22(6):1345–1352.
  • Sleight AG, Boyd P, Klein WMP, et al. Spiritual peace and life meaning may buffer the effect of anxiety on physical well-being in newly diagnosed cancer survivors. Psychooncology. 2021;30(1):52–58.
  • National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Cancer-Related Fatigue. 2023 January 30 [cited 2023 May 3]. Available from: https://www.nccn.org/professionals/physician_gls/pdf/fatigue.pdf.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.